Clinical Trial Update: Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates the efficacy of dapagliflozin for early diabetic nephropathy in individuals with Type 1 diabetes; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 1 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Diabetic Kidney Disease, Type 1 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING